- Home
- AMR vs DNTH Comparison
AMR vs DNTH Comparison
Compare AMR & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMR | DNTH |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AMR | DNTH |
|---|---|---|
| Price | $219.21 | $78.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $181.50 | $123.09 |
| AVG Volume (30 Days) | 279.1K | ★ 1.1M |
| Earning Date | 05-08-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,129,481,000.00 | $2,036,000.00 |
| Revenue This Year | $13.69 | N/A |
| Revenue Next Year | $14.62 | $30.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $100.00 | $13.37 |
| 52 Week High | $253.82 | $88.45 |
Technical Indicators
Market Signals| Indicator | AMR | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 68.01 | 67.84 |
| Support Level | $198.13 | $33.94 |
| Resistance Level | $253.82 | $88.45 |
| Average True Range (ATR) | 10.77 | 4.88 |
| MACD | 4.51 | -0.13 |
| Stochastic Oscillator | 92.56 | 68.24 |
Price Performance
Historical ComparisonAbout AMR Alpha Metallurgical Resources Inc.
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.